# US 2010/0144619 A1 · Antimicrobial Protein Specific to Staphylococcus Aureus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0144619 A1
- Document ID: US20100144619A1
- Status: Published application
- Kind: A1
- Application number: 12/308,627
- Filed: 2007-07-27
- Published: 2010-06-10
- Earliest claimed: 2006-08-04
- Assignees: Intron Biotechnology, Inc.
- Inventors: Seongjun Yoon; Sanghyeon Kang; Seobong Hyoung; Yunjaie Choi; Jeesoo Son
- Web page: https://patentgrep.com/patent/US20100144619A1

## CPC

- C07K 14/005: from viruses
- A61K 38/162: {from virus}
- A61P 31/04: Antibacterial agents
- C12N 2795/00022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a novel bacteriophage-originated protein having antimicrobial activity, more precisely an antimicrobial protein originated from lytic bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious diseases in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage-originated antimicrobial protein as an active ingredient.

## Claims

### Claim 1

An antimicrobial protein having killing activity specific to Staphylococcus aureus represented by the amino acid sequence represented by SEQ. ID. NO: 19.

### Claim 2 (depends on 1)

The antimicrobial protein according to claim 1, wherein the protein is originated from the bacteriophage of Accession No: KACC 97001P.

### Claim 3 (depends on 1)

A gene encoding the antimicrobial protein of claim 1.

### Claim 4 (depends on 3)

The gene according to claim 3, which has the nucleotide sequence represented by SEQ. ID. NO: 18.

### Claim 5 (depends on 1, 2)

A pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, containing the bacteriophage-originated antimicrobial protein of claim 1 or claim 2 as an active ingredient.

### Claim 6 (depends on 5)

The pharmaceutical composition according to claim 5, wherein the disease caused by Staphylococcus aureus is selected from the group consisting of mastitis, acute dermatitis, sepsis, pyogenic disease, food poisoning, pneumonia, osteomyelitis, impetigo, bacteremia, endocarditis and enteritis.

### Claim 7 (depends on 1, 2)

An antibiotic containing the bacteriophage-originated antimicrobial protein of claim 1 or claim 2 as an active ingredient.

### Claim 8 (depends on 1, 2)

A disinfectant containing the bacteriophage-originated antimicrobial protein of claim 1 or claim 2 as an active ingredient.
